Author details

Full Name

Aadel A Chaudhuri

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36658307	Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients.		2023
37657155	Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-invasive bladder cancer guided by modern clinical trials.		2023
37717084	First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound.	NPJ Precis Oncol	2023
37549060	PACT: a pipeline for analysis of circulating tumor DNA.	Bioinformatics	2023
37857854	High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.	NPJ Precis Oncol	2023
36973268	Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.	Nat Commun	2023
37084268	Cell-Free DNA Liquid Biopsy: The Epitome of Personalized Precision Oncology.		2023
37331781	Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology.		2023
37015072	Preservation of Proteins in Human Plasma through Metal-Organic Framework Encapsulation.		2023
37198186	Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.	Nat Commun	2023
36993328	Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.	Res Sq	2023
37491734	CD4 T cells and toxicity from immune checkpoint blockade.	Immunol Rev	2023
37349125	Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA.		2023
37097069	ctDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time?		2023
34875286	LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors.	Radiotherapy and Oncology	2022
35952319	Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.	JCO Precis Oncol	2022
35748739	Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.	Cancer Res	2022
35417204	Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.	JCO Precision Oncology	2022
36191390	Somatic mutation variant analysis in rural, resectable non-small cell lung carcinoma patients.	Cancer Genet	2022
35723337	Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients.	Curr Issues Mol Biol	2022
36427429	Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.	Cancer Treatment and Research Communications	2022
34987650	Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA.	Theranostics	2022
35279152	Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses.	Molecular Cancer	2022
34985936	Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent.	Journal of Clinical Oncology	2022
35027754	T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.	Nat Med	2022
34725800	Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors.		2021
34250420	ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine.	JCO Precis Oncol	2021
34029233	Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter, Prospective, and Retrospective Cohort.	Clin Transl Gastroenterol	2021
33307273	Immunity, immunotherapy, and rectal cancer: A clinical and translational science review.		2021
34464379	Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.	PLoS Medicine	2021
34464388	Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.	PLoS Med	2021
34905549	Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.	PLoS Medicine	2021
34505064	Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.	Nat Cancer	2020
32327175	Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer.	Thoracic Surgery Clinics	2020
32046999	Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.	Clin Cancer Res	2020
31711920	Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.	Gastroenterology	2020
32269342	Integrating genomic features for non-invasive early lung cancer detection.	Nature	2020
32923907	Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.	JCO Precision Oncology	2020
32903952	Cell-free DNA alterations in the <i>AR</i> enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancer.	JCO Precis Oncol	2020
33007267	Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.	Cell	2020
31300452	Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations.	Clin Cancer Res	2019
32030290	Local consolidative therapy for oligometastatic non-small cell lung cancer.	Journal of Thoracic Disease	2019
33880444	Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors.	Therapeutic Radiology and Oncology	2019
30578357	Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.	Cancer Discov	2019
31061481	Determining cell type abundance and expression from bulk tissues with digital cytometry.	Nat Biotechnol	2019
30941670	Detection of Solid Tumor Molecular Residual DiseaseÂ (MRD) Using Circulating Tumor DNA (ctDNA).		2019
29954647	Quantitative analysis of the safety and efficacy of microvascular decompression for patients with trigeminal neuralgia above and below 65â¿¯years of age.	Journal of Clinical Neuroscience	2018
27663899	Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.	Cancer Discov	2017
28460826	Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.	Radiotherapy and Oncology	2017
28899864	Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.	Cancer Discov	2017